PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program

Core Insights - PacBio has announced the inclusion of its Onso short-read sequencing platform in the 10x Genomics Compatible Partner Program, enhancing the range of sequencing solutions available to researchers globally [1][2][3] Company Overview - PacBio is a leading developer of high-quality genomic sequencing solutions, focusing on accuracy and performance in genomic research [1][4] - The company offers advanced sequencing technologies, including HiFi long-read sequencing and SBB® short-read sequencing, addressing various research applications such as human germline sequencing, oncology, and infectious diseases [4] Partnership Details - The Onso platform is designed for exceptional accuracy in short-read sequencing and is compatible with 10x Genomics' tools for single-cell and spatial biology applications [2][3] - This partnership aims to provide researchers with integrated workflows that enhance insights into genomics and transcriptomics, addressing key challenges in scientific research [2][3] Benefits of Collaboration - Streamlined workflows will allow researchers to access seamless end-to-end solutions by combining PacBio's Onso platform with 10x Genomics' technologies, improving data quality and efficiency [3] - The Onso platform is compatible with 10x Genomics' Single Cell 3' v3.1 assay, enhancing its application in genomic research [3] - PacBio's Onso platform delivers unmatched sequencing accuracy, further enhancing the precision of 10x Genomics' research tools [3][4] Industry Context - 10x Genomics is recognized for its products that accelerate the mastery of biology and advance human health, providing integrated solutions for single-cell and spatial biology [6] - The collaboration between PacBio and 10x Genomics is expected to push the boundaries of genomic science, enabling researchers to explore complex biological systems [3][4]